While most of the U.S. was battling snow and ice recently, I was out on our dock in Florida, soaking up the sun, my skin…
Adding Cablivi (caplacizumab) to therapeutic plasma exchange (TPE) and corticosteroids may lead to a faster treatment response and durable disease remission in people with acquired thrombotic thrombocytopenic purpura (aTTP), according to a report. The report describes the cases of three women in Slovakia, which showed that Cablivi contributed…
Latest news & perspectives
Adjusting the dose of oral eltrombopag — the active ingredient in Alvaiz and Promacta — based on how much of the drug is present in…
